Outset touts its new device, the Tablo, as the 1st dialysis machine designed as a consumer product, according to Warburg Pincus. The Vertical Group is also an investor, according to Outset’s website.
The Tablo comes with a touch-screen interface, purifies its own water and generates dialysate on demand, according to the site. The device can also schedule clinic visits from the main interface, and any errors or issues are displayed on screen.
Outset Medical is also pursuing FDA clearance for home use of the device, according to Warburg Pincus’ site, with an FDA pivotal trail slated to enroll patients this year. The Tablo is FDA-cleared for use in dialysis clinics and hospitals and set for an early market release to clinics later this year, the private equity shop said.
NxStage Medical’s System One home dialysis device won 510(k) clearance for nocturnal use last December, and clearance for high-flow use at home in early 2013. System One has been on the U.S. market for home use since June 2005.
Early rates for DeviceTalks Boston end August 15th.
Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.
View Full Agenda
Register today to save. Use code LASTCALL to save an additional 10%.